0001591890 false --12-31 2023 Q1 0001591890 2023-01-01 2023-03-31 0001591890 FGF:CommonStock0.001ParValuePerShareMember 2023-01-01 2023-03-31 0001591890 FGF:Sec8.00CumulativePreferredStockSeries25.00ParValuePerShareMember 2023-01-01 2023-03-31 0001591890 2023-05-12 0001591890 2023-03-31 0001591890 2022-12-31 0001591890 2022-01-01 2022-03-31 0001591890 us-gaap:PreferredStockMember 2021-12-31 0001591890 us-gaap:CommonStockMember 2021-12-31 0001591890 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001591890 us-gaap:RetainedEarningsMember 2021-12-31 0001591890 2021-12-31 0001591890 us-gaap:PreferredStockMember 2022-12-31 0001591890 us-gaap:CommonStockMember 2022-12-31 0001591890 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001591890 us-gaap:RetainedEarningsMember 2022-12-31 0001591890 us-gaap:PreferredStockMember 2022-01-01 2022-03-31 0001591890 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001591890 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001591890 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001591890 us-gaap:PreferredStockMember 2023-01-01 2023-03-31 0001591890 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001591890 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001591890 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001591890 us-gaap:PreferredStockMember 2022-03-31 0001591890 us-gaap:CommonStockMember 2022-03-31 0001591890 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001591890 us-gaap:RetainedEarningsMember 2022-03-31 0001591890 2022-03-31 0001591890 us-gaap:PreferredStockMember 2023-03-31 0001591890 us-gaap:CommonStockMember 2023-03-31 0001591890 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001591890 us-gaap:RetainedEarningsMember 2023-03-31 0001591890 FGF:FundamentalGlobalInvestorMember us-gaap:CommonStockMember 2023-03-31 0001591890 FGF:FGMergerCorpMember us-gaap:IPOMember 2022-03-02 2022-03-03 0001591890 FGF:FGAcquisitionCorpMember us-gaap:IPOMember us-gaap:FacilityClosingMember 2022-04-03 2022-04-05 0001591890 FGF:FGMergerCorpMember us-gaap:CommonStockMember 2023-03-31 0001591890 FGF:FGMergerCorpMember us-gaap:WarrantMember 2023-03-31 0001591890 FGF:FGMergerCorpMember FGF:WarrantOneMember 2023-03-31 0001591890 FGF:FGMergerCorpMember 2023-03-31 0001591890 FGF:FGAcquisitionCorpMember us-gaap:CommonStockMember 2023-03-31 0001591890 FGF:FGAcquisitionCorpMember us-gaap:WarrantMember 2023-03-31 0001591890 FGF:FGAcquisitionCorpMember FGF:WarrantOneMember 2023-03-31 0001591890 FGF:FGAcquisitionCorpMember us-gaap:WarrantMember srt:MaximumMember 2023-03-31 0001591890 FGF:FGCommunitiesIncMember 2022-12-31 0001591890 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember FGF:FundamentalGlobalAssetManagementLLCMember 2020-09-30 0001591890 FGF:FGCommunitiesIncMember 2022-10-31 0001591890 2023-01-01 0001591890 FGF:FGCommunitiesIncMember 2023-03-31 0001591890 FGF:HagertyCommonStockMember 2022-12-31 0001591890 FGF:HagertyCommonStockMember 2022-01-01 2022-12-31 0001591890 2022-01-01 2022-12-31 0001591890 FGF:HagertyCommonStockMember 2022-12-14 2022-12-15 0001591890 FGF:FGSPACPartnersLPMember 2021-01-04 0001591890 FGF:FGMPMember 2023-01-01 2023-03-31 0001591890 FGF:FGSPACPartnersLPMember 2023-01-01 2023-03-31 0001591890 FGF:FGSPACPartnersLPMember 2022-01-01 2022-12-31 0001591890 FGF:FGSPACPartnersLPMember 2023-03-31 0001591890 FGF:FGSPACPartnersLPMember srt:MaximumMember 2023-03-31 0001591890 FGF:FGSPACPartnersLPMember 2023-03-31 0001591890 FGF:InvestmentFundMember 2023-03-31 0001591890 FGF:InvestmentFundMember 2022-01-01 2022-12-31 0001591890 FGF:FundamentalGlobalCommitiesMember 2023-03-31 0001591890 FGF:OtherInvestmentMember 2023-03-31 0001591890 FGF:OtherInvestmentMember 2022-12-31 0001591890 FGF:ICoreConnectIncMember 2023-03-15 0001591890 FGF:ICoreConnectIncMember 2023-03-15 2023-03-15 0001591890 FGF:ICoreConnectIncMember 2023-03-31 0001591890 FGF:CraveworthyMember 2023-03-16 0001591890 FGF:CraveworthyMember 2023-03-16 2023-03-16 0001591890 FGF:EquityMethodInvestmentMember 2023-03-31 0001591890 FGF:EquityMethodInvestmentMember 2022-12-31 0001591890 FGF:EquityMethodInvestmentMember 2023-01-01 2023-03-31 0001591890 FGF:EquityMethodInvestmentMember 2022-01-01 2022-03-31 0001591890 FGF:RealizedLossOnFedNatCommonStockMember 2023-01-01 2023-03-31 0001591890 FGF:RealizedLossOnFedNatCommonStockMember 2022-01-01 2022-03-31 0001591890 FGF:UnrealizedHoldingLossOnFedNatCommonStockMember 2023-01-01 2023-03-31 0001591890 FGF:UnrealizedHoldingLossOnFedNatCommonStockMember 2022-01-01 2022-03-31 0001591890 FGF:RealizedLossOnHagertyCommonStockMember 2023-01-01 2023-03-31 0001591890 FGF:RealizedLossOnHagertyCommonStockMember 2022-01-01 2022-03-31 0001591890 FGF:UnrealizedHoldingLossOnHagertyCommonStockMember 2023-01-01 2023-03-31 0001591890 FGF:UnrealizedHoldingLossOnHagertyCommonStockMember 2022-01-01 2022-03-31 0001591890 FGF:EquityMethodEarningsLossesMember 2023-01-01 2023-03-31 0001591890 FGF:EquityMethodEarningsLossesMember 2022-01-01 2022-03-31 0001591890 FGF:OtherInvestmentIncomeMember 2023-01-01 2023-03-31 0001591890 FGF:OtherInvestmentIncomeMember 2022-01-01 2022-03-31 0001591890 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember FGF:HagertyCommonStockMember 2022-12-31 0001591890 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember FGF:HagertyCommonStockMember 2022-12-31 0001591890 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember FGF:HagertyCommonStockMember 2022-12-31 0001591890 us-gaap:FairValueMeasurementsRecurringMember FGF:HagertyCommonStockMember 2022-12-31 0001591890 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001591890 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001591890 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001591890 us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001591890 FGF:ExpireOnDecemberThirtyOneTwoThousandAndThirtyNineMember 2023-03-31 0001591890 FGF:ExpireOnDecemberThirtyOneTwoThousandAndFourtyMember 2023-03-31 0001591890 FGF:ExpireOnDecemberThirtyOneTwoThousandAndFourtyOneMember 2023-03-31 0001591890 FGF:NotExpireUnderCurrentTaxLawMember 2023-03-31 0001591890 FGF:ExpireOnDecemberTwoThousandAndTwentySixMember 2023-03-31 0001591890 FGF:TwoThousandAndTwentyOneIncentivePlanMember srt:MaximumMember 2021-12-15 0001591890 FGF:TwoThousandAndTwentyOneIncentivePlanMember 2023-03-24 0001591890 FGF:AmendmentTwoThousandAndTwentyOneIncentivePlanMember 2023-03-24 0001591890 FGF:TwoThousandAndTwentyOneIncentivePlanMember us-gaap:RestrictedStockUnitsRSUMember 2023-03-31 0001591890 FGF:TwoThousandAndTwentyOneIncentivePlanMember 2023-03-31 0001591890 FGF:NonEmployeeDirectorMember us-gaap:RestrictedStockUnitsRSUMember 2022-08-18 2022-08-19 0001591890 srt:ManagementMember us-gaap:RestrictedStockUnitsRSUMember 2023-02-16 2023-02-17 0001591890 FGF:LarryGSwetsJrMember FGF:EquityAwardLetterAgreementMember 2021-01-17 2021-01-18 0001591890 FGF:MrSwetsMember us-gaap:RestrictedStockUnitsRSUMember 2023-02-16 2023-02-17 0001591890 FGF:EmployeeDirectorMember us-gaap:RestrictedStockUnitsRSUMember FGF:TwentyTwentyOneEquityIncentivePlanMember 2022-07-30 2022-07-31 0001591890 FGF:LarryGSwetsJrMember FGF:StockOptionAgreementMember 2021-01-10 2021-01-12 0001591890 FGF:StockOptionAgreementMember FGF:LarryGSwetsJrMember 2023-01-01 2023-03-31 0001591890 us-gaap:WarrantMember 2022-02-24 0001591890 us-gaap:RestrictedStockUnitsRSUMember 2022-12-31 0001591890 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-03-31 0001591890 us-gaap:RestrictedStockUnitsRSUMember 2023-03-31 0001591890 us-gaap:RestrictedStockUnitsRSUMember 2021-12-31 0001591890 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-03-31 0001591890 us-gaap:RestrictedStockUnitsRSUMember 2022-03-31 0001591890 FGF:TwoThousandAndFourteenEquityIncentivePlanMember 2022-12-31 0001591890 FGF:TwoThousandAndFourteenEquityIncentivePlanMember 2023-01-01 2023-03-31 0001591890 FGF:TwoThousandAndFourteenEquityIncentivePlanMember 2023-03-31 0001591890 FGF:TwoThousandAndFourteenEquityIncentivePlanMember 2021-12-31 0001591890 FGF:TwoThousandAndFourteenEquityIncentivePlanMember 2022-01-01 2022-03-31 0001591890 FGF:TwoThousandAndFourteenEquityIncentivePlanMember 2022-03-31 0001591890 FGF:JointVentureAgreementMember FGF:FundamentalGlobalAssetManagementMember 2020-03-31 0001591890 2023-03-16 0001591890 FGF:SharedServicesAgreementMember FGF:FundamentalGlobalManagementLLCMember 2020-03-30 2020-03-31 0001591890 FGF:SharedServicesAgreementMember FGF:FundamentalGlobalManagementLLCMember 2023-01-01 2023-03-31 0001591890 FGF:SharedServicesAgreementMember FGF:FundamentalGlobalManagementLLCMember 2022-01-01 2022-03-31 0001591890 FGF:WarrantsToPurchaseCommonStockMember 2023-01-01 2023-03-31 0001591890 FGF:WarrantsToPurchaseCommonStockMember 2022-01-01 2022-03-31 0001591890 us-gaap:StockOptionMember 2023-01-01 2023-03-31 0001591890 us-gaap:StockOptionMember 2022-01-01 2022-03-31 0001591890 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-03-31 0001591890 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-03-31 0001591890 FGF:LeaseAgreementMember 2021-07-31 0001591890 FGF:LeaseAgreementMember 2023-01-01 2023-03-31 0001591890 FGF:LeaseAgreementMember 2022-01-01 2022-03-31 0001591890 FGF:LeaseAgreementMember 2022-04-30 0001591890 FGF:UnrestrictedCashMember 2023-03-31 0001591890 FGF:UnrestrictedCashMember 2022-03-31 0001591890 FGF:InsuranceMember 2023-01-01 2023-03-31 0001591890 FGF:AssetManagementMember 2023-01-01 2023-03-31 0001591890 us-gaap:AllOtherSegmentsMember 2023-01-01 2023-03-31 0001591890 FGF:InsuranceMember 2023-03-31 0001591890 FGF:AssetManagementMember 2023-03-31 0001591890 us-gaap:AllOtherSegmentsMember 2023-03-31 0001591890 FGF:InsuranceMember 2022-01-01 2022-03-31 0001591890 FGF:AssetManagementMember 2022-01-01 2022-03-31 0001591890 us-gaap:AllOtherSegmentsMember 2022-01-01 2022-03-31 0001591890 FGF:InsuranceMember 2022-03-31 0001591890 FGF:AssetManagementMember 2022-03-31 0001591890 us-gaap:AllOtherSegmentsMember 2022-03-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 10-Q

 

(Mark One)

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the Quarterly Period Ended March 31, 2023

 

Or

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Commission File Number: 001-36366

 

FG Financial Group, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Nevada   46-1119100

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

 

104 S. Walnut Street, Unit 1A, Itasca, IL 60143

(Address of principal executive offices and zip code)

 

(847)773-1665

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name, former address and former fiscal year, if changed since last report)

 

 

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, $0.001 par value per share   FGF   The Nasdaq Stock Market LLC
8.00% Cumulative Preferred Stock, Series A, $25.00 par value per share   FGFPP   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer Smaller Reporting Company Emerging Growth Company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No

 

The number of shares outstanding of the registrant’s common stock as of May 12, 2023 was 9,438,739.

 

 

 

 

 

 

Table of Contents

 

PART I. FINANCIAL INFORMATION 3
   
ITEM 1. FINANCIAL STATEMENTS 3
   
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 26
   
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 35
   
ITEM 4. CONTROLS AND PROCEDURES 35
   
PART II. OTHER INFORMATION 36
   
ITEM 1. LEGAL PROCEEDINGS 36
   
ITEM 1A. RISK FACTORS 36
   
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS 36
   
ITEM 3. DEFAULTS UPON SENIOR SECURITIES 36
   
ITEM 4. MINE SAFETY DISCLOSURES 36
   
ITEM 5. OTHER INFORMATION 36
   
ITEM 6. EXHIBITS 36
   
SIGNATURES 37

 

2

 

 

PART I. FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

 

FG FINANCIAL GROUP, INC.

Consolidated Balance Sheets

($ in thousands, except per share data)

 

  

March 31, 2023

(unaudited)

  

December 31,

2022

 
ASSETS          
Equity securities, at fair value (cost basis of zero and $889, respectively)  $-   $841 
Other investments   27,475    24,839 
Cash and cash equivalents   4,304    3,010 
Deferred policy acquisition costs   1,270    1,527 
Reinsurance balances receivable (net of current expected losses allowance of $106 and zero, respectively)   9,702    9,269 
Funds deposited with reinsured companies   6,513    9,277 
Other assets   740    712 
Total assets  $50,004   $49,475 
           
LIABILITIES          
Loss and loss adjustment expense reserves  $4,044   $4,409 
Unearned premium reserves   6,530    6,823 
Accounts payable   433    723 
Other liabilities   190    225 
Total liabilities  $11,197   $12,180 
           
Commitments and contingencies (Note 10)   -     -  
           
SHAREHOLDERS’ EQUITY          
Series A Preferred Shares, $25.00 par and liquidation value, 1,000,000 shares authorized; 894,580 shares issued and outstanding as of March 31, 2023 and December 31, 2022  $22,365   $22,365 
Common stock, $0.001 par value; 100,000,000 shares authorized; 9,438,739 and 9,410,473 shares issued and outstanding as of March 31, 2023 and December 31, 2022, respectively   9    9 
Additional paid-in capital   50,736    50,021 
Accumulated deficit   (34,303)   (35,100)
Total shareholders’ equity   38,807    37,295 
Total liabilities and shareholders’ equity  $50,004   $49,475 

 

See accompanying notes to consolidated financial statements

 

3

 

 

FG FINANCIAL GROUP, INC.

Consolidated Statements of Operations

($ in thousands, except per share data)

(Unaudited)

 

   2023   2022 
   Three months ended March 31, 
   2023   2022 
Revenue:          
Net premiums earned  $3,657   $2,473 
Net investment income (loss)   2,840    (2,346)
Other income   30    25 
Total revenue   6,527    152 
           
Expenses:          
Net losses and loss adjustment expenses   1,917    1,524 
Amortization of deferred policy acquisition costs   713    712 
General and administrative expenses   2,547    1,739 
Total expenses   5,177    3,975 
           
Income (loss) before income taxes   1,350    (3,823)
Income taxes        
Net Income (loss)  $1,350   $(3,823)
           
Dividends declared on Series A Preferred Shares   447    447 
Income (loss) attributable to FG Financial Group, Inc. common shareholders  $903   $(4,270)
           
Basic and diluted net income (loss) per common share:          
Basic  $0.10   $(0.66)
Diluted  $0.10     (0.66)
Weighted average common shares outstanding:          
Basic and diluted   9,421,993    6,477,568 

 

See accompanying notes to consolidated financial statements

 

4

 

 

FG FINANCIAL GROUP, INC.

Consolidated Statements of Shareholders’ Equity

(Unaudited)

($ in thousands)

 

   Shares   Amount   Shares   Amount   Capital   Deficit   FG Financial Inc. 
   Preferred Stock   Common Stock   Paid-in   Accumulated   Total Shareholders’ Equity attributable to  
   Shares   Amount   Shares   Amount   Capital   Deficit   FG Financial Inc. 
Balance, January 1, 2022   894,580   $22,365    6,497,205   $6   $46,037   $(34,399)  $34,009 
Stock based compensation           30,796    1    62        63 
Dividends declared on Series A Preferred Shares ($0.50 per share)                       (447)   (447)
Interests issued for contributed cash                            
Net income (loss)                       (3,823)   (3,823)
Balance, March 31, 2022   894,580   $22,365    6,528,001   $7   $46,099   $(38,669)  $29,802 
                                    
Balance, January 1, 2023   894,580   $22,365    9,410,473   $9   $50,021   $(35,100)  $37,295 
Common stock issuance   -    -    27,186    -    74    -    74 
Stock based compensation           1,080    -    641        641 
Dividends declared on Series A Preferred Shares ($0.50 per share)                       (447)   (447)
Net income                       1,350    1,350 
Cumulative effect of adoption of accounting guidance for expected credit losses at January 1, 2023                            (106)   (106)
Balance, March 31, 2023   894,580   $22,365    9,438,739   $9   $50,736   $(34,303)  $38,807 

 

See accompanying notes to consolidated financial statements

 

5

 

 

FG FINANCIAL GROUP, INC.

Consolidated Statement of Cash Flows

(Unaudited)

(in thousands)

 

   2023   2022 
   Three months ended March 31, 
   2023   2022 
Cash flows from operating activities:          
Net income (loss)  $1,350   $(3,823)
Adjustments to reconcile net income (loss) to net cash provided (used) by operating activities:          
Net unrealized holding gain on equity investments   (48)   (2,774)
(Income) loss from equity method investments   (2,680)   5,273 
Net realized loss on sale of equity investments   16    2,877 
Stock compensation expense   641    63 
Changes in operating assets and liabilities:          
Funds deposited with reinsurance companies   2,763     
Reinsurance balances receivable   (540)   80 
Deferred policy acquisition costs   258    87 
Other assets and receivables   (27)   (1,783)
Loss and loss adjustment expense reserves   (365)   (178)
Unearned premium reserves   (294)   (372)
Accounts payable and other liabilities   (324)   (428)
Net cash provided (used) by operating activities   750    (978)
           
Cash flows from investing activities:          
Purchases of furniture and equipment   -    (1)
Purchases of equity method investments   (50)   (6,781)
Distribution from equity method investments   761    808 
Purchases of other investments   (700)   - 
Proceeds from sales of equity securities   873    251 
Return of capital – other investments   33    107 
Net cash provided (used) by investing activities   917    (5,616)
           
Cash flows from financing activities:          
Proceeds from issuance of common stock, net   74    - 
Payment of dividends on preferred shares   (447)   (447)
Net cash used by financing activities   (373)   (447)
           
Net decrease in cash and cash equivalents   1,294    (7,041)
Cash and cash equivalents at beginning of period   3,010    15,542 
Cash and cash equivalents at end of period  $4,304   $8,501 

 

See accompanying notes to consolidated financial statements

 

6

 

 

Note 1. Nature of Business

 

FG Financial Group, Inc. (“FGF”, the “Company”, “we”, or “us”) is a reinsurance, merchant banking and asset management holding company. We focus on opportunistic collateralized and loss capped reinsurance, while allocating capital in partnership with Fundamental Global®, and from time to time, other strategic investors, to merchant banking activities. The Company’s principal business operations are conducted through its subsidiaries and affiliates. The Company also provides asset management services.

 

From our inception in October 2012 through December 2019, we operated as an insurance holding company, writing property and casualty insurance throughout the states of Louisiana, Florida, and Texas. On December 2, 2019, we sold our three former insurance subsidiaries to FedNat Holding Company for a combination of cash and FedNat common stock, and embarked upon our current strategy focused on reinsurance, merchant banking and asset management.

 

As of March 31, 2023, FG Financial Holdings, LLC (“FG”), a private partnership focused on long-term strategic holdings, and its affiliated entity, collectively beneficially owned approximately 60.0% of our common stock. D. Kyle Cerminara, Chairman of our Board of Directors, serves as Chief Executive Officer, Co-Founder and Partner of FG.

 

Reincorporation

 

Effective at 5:01 p.m. ET on December 9, 2022, the Company completed its reincorporation from a Delaware corporation to a Nevada corporation (the “Reincorporation”). The Reincorporation was accomplished by means of a merger by and between the Company and its former wholly owned subsidiary FG Financial Group, Inc., a Nevada corporation. As of December 9, 2022, the rights of the Company’s stockholders began to be governed by the Nevada corporation laws, our Amended and Restated Nevada Articles of Incorporation and our Nevada Bylaws. The Reincorporation was approved by the Company’s stockholders at a special meeting held on December 6, 2022.

 

Other than the change in the state of incorporation, the Reincorporation did not result in any change in the business, physical location, management, assets, liabilities or net worth of the Company, nor did it result in any change in location of the Company’s employees, including the Company’s management.

 

The Reincorporation did not alter any stockholder’s percentage ownership interest or number of shares owned in the Company and the Company’s common stock continues to be quoted on the Nasdaq Global Market under the same symbol “FGF” and the 8.00% Cumulative Preferred Stock, Series A of the Company continues to be quoted on the Nasdaq Global Market under the same symbol, “FGFPP.”

 

Current Business

 

Our strategy has evolved to focus on opportunistic collateralized and loss capped reinsurance, with capital allocation to merchant banking activities with asymmetrical risk/reward opportunities. As part of our refined focus, we have adopted the following capital allocation philosophy:

 

Grow intrinsic value per share with a long-term focus using fundamental research, allocating capital to asymmetric risk/reward opportunities.”

 

Currently, the business operates as a diversified holding company of insurance, reinsurance, asset management, our Special purpose acquisition corporation “SPAC” Platform businesses, and our merchant banking division.

 

7

 

 

Insurance

 

Sponsor Protection Coverage and Risk, Inc. is being formed as a special purpose captive in South Carolina to provide reinsurance coverage for Sides A, B, & C Directors and Officers Liability insurance coverage for related and unrelated entities of FG Reinsurance Ltd (“FGRe”). These will include SPAC entities engaged in the services or business of taking companies public, as well as small cap businesses performing an initial public offering.

 

Reinsurance

 

The Company’s wholly owned reinsurance subsidiary, FGRe, a Cayman Islands limited liability company, provides specialty property and casualty reinsurance. FGRe has been granted a Class B (iii) insurer license in accordance with the terms of The Insurance Act (as revised) of the Cayman Islands and underlying regulations thereto and is subject to regulation by the Cayman Islands Monetary Authority (the “Authority”). The terms of the license require advance approval from the Authority should FGRe wish to enter into any reinsurance agreements which are not fully collateralized.

 

FGRe participates in a Funds at Lloyds (“FAL”) syndicate covering risks written by the syndicate during the 2021 and 2022 calendar years, and on December 10, 2022 agreed to cover risks written by the syndicate during the calendar year 2023. On April 1, 2021, FGRe entered its second reinsurance contract with a leading insurtech company that provides automotive insurance utilizing driver monitoring to predictively segment and price drivers. The Company added a second agreement with the automotive insurance provider as of April 1, 2022. Beginning January 1, 2022, FGRe participates in a quota share reinsurance contract with a startup homeowners’ insurance company. These agreements limit exposure by loss-caps stipulated within the reinsurance contracts.

 

Asset Management

 

FG Strategic Consulting, LLC, (“FGSC”) a wholly-owned subsidiary of the Company, looks to provide investment advisory services, including identifying, analyzing and recommending potential investments, advising as to existing investments and investment optimization, recommending investment dispositions, and providing advice regarding macro-economic conditions.

 

SPAC Platform

 

On December 21, 2020, we formed FG Management Solutions LLC (“FGMS”), formerly known as FG SPAC Solutions, LLC, a Delaware company, to facilitate the launch of our “SPAC Platform”. Under the SPAC Platform, we provide various strategic, administrative, and regulatory support services to newly formed SPACs for a monthly fee. Additionally, the Company co-founded a partnership, FG Merchant Partners, LP (“FGMP”), formerly known as FG SPAC Partners, LP, to participate as a co-sponsor for newly formed SPACs. The first transaction entered under the SPAC Platform occurred on January 11, 2021, by and among FGMS and Aldel Investors, LLC, the sponsor of Aldel Financial, Inc. (“Aldel”), a special purpose acquisition company which completed its business combination with Hagerty (NYSE: HGTY) on December 2, 2021. Under the services agreement between FGMS and Aldel Investors, LLC (the “Agreement”), FGMS provided accounting, regulatory, strategic advisory, and other administrative services to Aldel, which included assistance with negotiations with potential merger targets for the SPAC as well as assistance with the de-SPAC process.

 

In March and April 2022, the Company continued to build upon its SPAC Platform strategy. On March 3, 2022, FG Merger Corp. (“FG Merger”) (Nasdaq: FGMCU) announced the closing of an $80.5 million IPO in the United States, including the exercise of the over-allotment option granted to the underwriters in the offering. Similarly, on April 5, 2022, FG Acquisition Corp. (“FG Acquisition”) (TSX:FGAA.V), announced the closing of a $115 million IPO in Canada, including the exercise of the over-allotment option granted to the underwriters in the offering. The Company participated in the risk capital associated with the launch of the SPACs.

 

In the aggregate, the Company’s exposure to FG Merger through its ownership in FG Special Situations Fund, LP and FGMP represents potential beneficial ownership of approximately 820,000 shares of FG Merger’s common stock, approximately 989,000 warrants with an $11.50 exercise price and 5-year expiration, and approximately 85,000 warrants with a $15.00 exercise price and 10-year expiration. The Company has invested approximately $2.6 million in FG Merger through its subsidiaries. The Company’s indirect exposure in FG Acquisition through its subsidiaries represents potential beneficial ownership of approximately 819,000 shares of FG Acquisition’s common stock, approximately 1,400,000 warrants with an $11.50 exercise price and 5-year expiration (the “FGAC Warrants”), approximately 440,000 warrants with a $15 exercise price and 10-year expiration, and either (i) up to approximately an additional 1,600,000 FGAC Warrants, or (ii) up to approximately $2 million in cash, or (iii) a pro-rata combination of such FGAC Warrants and cash, based on certain adjustment provisions and the level of redemptions of FG Acquisition’s publicly traded warrants at the time of a business combination. The Company has invested approximately $3.4 million in FG Acquisition through its subsidiaries.

 

Merchant Banking

 

In Q3 2022, the Company announced the expansion of its growth strategy through the formation of a merchant banking division.

 

8

 

 

In the fourth quarter of 2022, the Company invested $2.0 million into its first project launched under the platform, FG Communities, Inc (“FGC”). FGC is a self-managed real estate company focused on a growing portfolio of manufactured housing communities which are owned and operated by FGC. As discussed further in Note 4, the Company holds the $2.0 million investment at cost, subject to any adjustment from time to time due to impairment or observable price changes in orderly transactions. The Company also holds an indirect interest in FGC through its limited ownership in FGMP.

 

Note 2. Significant Accounting Policies

 

Basis of Presentation

 

These statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”).

 

Consolidation Policies

 

The accompanying consolidated financial statements include the accounts of the Company and its subsidiaries. All significant intercompany balances and transactions have been eliminated upon consolidation.

 

The consolidated financial statements include the accounts of the Company and entities in which it is required to consolidate under either the Variable Interest Entity (“VIE”) or Voting Interest Entity (“VOE”) models. Both models require the reporting entity to identify whether it has a controlling financial interest in a legal entity and is therefore required to consolidate the legal entity. Under the VOE model, a reporting entity with ownership of a majority of the voting interest of a legal entity is generally considered to have a controlling financial interest. The VIE model was established for situations in which control may be demonstrated other than by the possession of voting rights in a legal entity and instead focuses on the power to direct the activities that most significantly impact the legal entity’s economic performance, as well as the rights to receive benefits and obligations to absorb losses that could potentially be significant to the legal entity.

 

The determination of whether a legal entity is consolidated under either model is reassessed where there is a substantive change in the governing documents or contractual arrangements of the entity, to the capital structure of the entity or in the activities of the entity. The Company continuously reassesses whether it should consolidate under either model.

 

In September 2020, the Company invested approximately $5.0 million to sponsor the launch of the FG Special Situations Fund, LP (“The Fund”). The Fund, a VIE which the Company was required to consolidate through November 30, 2021, is considered an investment company for GAAP purposes and follows the accounting and reporting guidance in the Financial Accounting Standards Codification (“ASC”) Topic 946, Financial Services-Investment Companies, which includes the presentation of its investments at fair value. On December 1, 2021, the Company’s investment became that of a limited partner, and it no longer had the power to govern the financial and operating policies of the Fund, and thus, began to account for its investment in the Fund under the equity method of accounting. During the first quarter of 2023, it was determined that the Fund would begin the process of winding down. All investment holdings currently held in the name of the Fund will be transferred or distributed to members within the fund based on their ownership percentage of each respective holding. As previously discussed, the Fund currently accounts for its investment holdings at fair value, and the Company expects to continue to hold the investments at fair value subsequent to the transfer. The process is expected to be completed sometime during the second quarter of 2023. The Company does not expect any impact to shareholders’ equity as a result of the Fund winding down.

 

In October of 2022, the Company invested $2.0 million into FGC, which the Company has determined meets the criteria of a VIE. The Company holds this investment at cost, subject to any adjustment from time to time due to impairment or observable price changes in orderly transactions. Due to its minority interest and inability to govern the financial and operating policies of FGC, the Company has determined it is not the primary beneficiary of FGC, and thus does not consolidate FGC.

 

9

 

 

The Use of Estimates in the Preparation of Consolidated Financial Statements

 

The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the application of policies and the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses for the reporting period. Actual results could differ from these estimates. Estimates and their underlying assumptions are reviewed on an ongoing basis. Changes in estimates are recorded in the accounting period in which they are determined. The critical accounting estimates and assumptions in the accompanying consolidated financial statements include the valuation of our investments, current expected credit losses, the valuation of net deferred income taxes and deferred policy acquisition costs, premium revenue recognition, reserves for loss and loss adjustment expenses, and stock-based compensation expense.

 

Investments in Equity Securities

 

Investments in equity securities are carried at fair value with subsequent changes in fair value recorded to the Consolidated Statements of Operations as a component of net investment income.

 

Other Investments

 

Other investments consist, in part, of equity investments made in privately held companies accounted for under the equity method. We utilize the equity method to account for investments when we possess the ability to exercise significant influence, but not control, over the operating and financial policies of the investee. The ability to exercise significant influence is presumed when the investor possesses more than 20% of the voting interests of the investee. This presumption may be overcome based on specific facts and circumstances that demonstrate that the ability to exercise significant influence is restricted. We apply the equity method to investments in common stock and to other investments when such other investments possess substantially identical subordinated interests to common stock.

 

In applying the equity method, we record the investment at cost and subsequently increase or decrease the carrying amount of the investment by our proportionate share of the net earnings or losses and other comprehensive income of the investee. We record dividends or other equity distributions as reductions in the carrying value of the investment. Should net losses of the investee reduce the carrying amount of the investment to zero, additional net losses may be recorded if other investments in the investee are at-risk, even if we have not committed to provide financial support to the investee. Such additional equity method losses, if any, are based upon the change in our claim on the investee’s book value.

 

When we receive distributions from our equity method investments, we utilize the cumulative earnings approach. When classifying the related cash flows under this approach, the Company compares the cumulative distributions received, less distributions received in prior periods, with the Company’s cumulative equity in earnings. Cumulative distributions that do not exceed cumulative equity in earnings represent returns on investment and are classified as cash inflows from operating activities. Cumulative distributions in excess of cumulative equity in earnings represent returns on investment and are classified as cash inflows from investing activities.

 

In addition to investments accounted for under the equity method of accounting, other investments also consists of equity we have purchased in a limited partnership, a limited liability company, and a corporation for which there does not exist a readily determinable fair value. The Company accounts for these investments at their cost, minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for identical or similar investments by the same issuer. Any profit distributions the Company receives on these investments are included in net investment income.

 

Other investments also include a convertible promissory note in the amount of $500,000 due from iCoreConnect Inc (“iCore”). and a senior unsecured promissory note of $200,000 due from Craveworthy.

 

See Note 4 for additional information regarding the Company’s other investments.

 

Cash and Cash Equivalents

 

Cash and cash equivalents include cash and highly liquid investments with original maturities of 90 days or less.

 

10

 

 

Pursuant to the Company’s insurance license, the Authority has required that FGRe hold a minimum capital requirement of $200,000 in cash in a bank in the Cayman Islands which holds an “A” license issued under the Banks and Trust Companies Act (2020 Revision).

 

Income Taxes

 

The Company follows the asset and liability method of accounting for income taxes, whereby deferred income tax assets and liabilities are recognized for (i) the differences between the financial statement carrying amount of existing assets and liabilities and their respective tax bases and (ii) loss and tax credit carry-forwards. Deferred income tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the date of enactment. Future tax benefits are recognized to the extent that realization of such benefits is more likely than not and a valuation allowance is established for any portion of a deferred tax asset that management believes will not be realized. Current federal income taxes are charged or credited to operations based upon amounts estimated to be payable or recoverable as a result of taxable operations for the current year. The Company recognizes interest and penalties, if any, related to unrecognized tax benefits in income tax expense (benefit).

 

Concentration of Credit Risk

 

Financial instruments which potentially expose the Company to concentrations of credit risk include investments, cash, and deposits with reinsured companies. The Company maintains its cash with a major U.S. domestic banking institution which is insured by the Federal Deposit Insurance Corporation (“FDIC”) for up to $250,000. As of March 31, 2023, the Company held funds in excess of these FDIC insured amounts. The terms of these deposits are on demand to mitigate some of the associated risk. The Company has not incurred losses related to these deposits.

 

Premium Revenue Recognition

 

The Company participates in quota-share contracts and estimates the ultimate premiums for the contract period. These estimates are based on information received from the ceding companies, whereby premiums are recorded as written in the same periods in which the underlying insurance contracts are written and are based on cession statements from cedents. These statements are received quarterly and in arrears, and thus, for any reporting lag, premiums written are estimated based on the portion of the ultimate estimated premiums relating to the risks underwritten during the lag period.

 

Premium estimates are reviewed by management periodically. Such review includes a comparison of actual reported premiums to expected ultimate premiums. Based on management’s review, the appropriateness of the premium estimates is evaluated, and any adjustments to these estimates are recorded in the period in which they are determined. Changes in premium estimates, including premiums receivable, are not unusual and may result in significant adjustments in any period. A significant portion of amounts included in the caption “Reinsurance balances receivable” in the Company’s consolidated balance sheets represents estimated premiums written, net of commissions, brokerage, and loss and loss adjustment expense, and are not currently due based on the terms of the underlying contracts. Additional premiums due on a contract that has no remaining coverage period are earned in full when written.

 

Premiums written are generally recognized as earned over the contract period in proportion to the risk covered. Unearned premiums represent the unexpired portion of reinsurance provided.

 

Current Expected Credit Loss

 

In the first quarter of 2023, the Company adopted ASU 2016-13, as amended, Financial Instruments – Credit Losses (“ASU 2016-13”), which requires an entity to estimate its lifetime “expected credit loss” and record an allowance that, when deducted from the amortized cost basis of the financial asset, presents the net amount expected to be collected on the financial asset. The financial assets included in the caption “Reinsurance balances recoverable” in the Company’s consolidated balance sheets are carried at amortized cost and therefore affected by ASU 2016-13. The amendments in this update were effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years, with early adoption permitted, however smaller reporting companies, like the Company, could delay adoption until January 2023. Upon adoption of ASU 2016-13, the Company calculated an allowance for expected credit losses for its reinsurance balances receivable by applying a Probability of Default / Loss Given Default model. The model considers both the external collectability history as well as external loss history. The external loss history that the Company used included a long-term probability of liquidation study specific to insurance companies. Additionally, the life of each of the Company’s reinsurance treaties was also considered as the probability of default was calculated over the contractual length of the reinsurance contracts. The credit worthiness of a counterparty is evaluated by considering the credit ratings assigned by independent agencies and individually evaluating all the counterparties. The adoption resulted in a cumulative-effect adjustment to increase accumulated deficit by $0.1 million as of January 1, 2023. The Company updated the model as of March 31, 2023, but due to immateriality, did not adjust the allowance for expected credit losses.

 

In the first quarter of 2023, the Company invested of $200,000 into a promissory note. The promissory note is carried at amortized cost on the Company’s consolidated balance sheet under the caption “other investments”. Due to being held at amortized cost, the promissory note falls into the scope of ASU 2016-13. The Company does not have a current expected credit allowance against the promissory note.

 

11

 

 

Deferred Policy Acquisition Costs

 

Policy acquisition costs are costs that vary with, and are directly related to, the successful production of new and renewal business, and consist principally of commissions, taxes and brokerage expenses. If the sum of a contract’s expected losses and loss expenses and deferred acquisition costs exceeds associated unearned premiums and expected investment income, a premium deficiency is determined to exist. In this event, deferred acquisition costs are written off to the extent necessary to eliminate the premium deficiency. If the premium deficiency exceeds deferred acquisition costs then a liability is accrued for the excess deficiency. There were no premium deficiency adjustments recognized during the periods presented herein.

 

Funds Deposited for benefit of Reinsured Companies

 

“Funds Deposited with Reinsured Companies” on the Company’s consolidated balance sheets includes amounts held by cedents provided to support our reinsurance contracts. As of March 31, 2023 and December 31, 2022, the total cash collateral posted to support all of our reinsurance treaties was approximately $6.5 million and $9.3 million, respectively.

 

Loss and Loss Adjustment Expense Reserves

 

The Company maintains reserves equal to our estimated ultimate liability for losses and loss adjustment expense for reported and unreported claims from our reinsurance business. Loss and loss adjustment reserve estimates are based primarily on estimates derived from reports the Company has received from ceding companies. The Company then uses a variety of statistical and actuarial techniques to monitor reserve adequacy. When setting reserves, the Company considers many factors including: (1) the types of exposures and projected ultimate premium to be written by our cedants; (2) expected loss ratios by type of business; (3) actuarial methodologies which analyze loss reporting and payment experience, reports from ceding companies and historical trends; and (4) general economic conditions. The Company also engages independent actuarial specialists, at least annually, to assist management in establishing appropriate reserves. Since reserves are estimates, the final settlement of losses may vary from the reserves established, and any adjustments to the estimates, which may be material, are recorded in the period they are determined. The final settlement of losses may vary, perhaps materially, from the reserves recorded.

 

U.S. GAAP does not permit establishing loss reserves, which include case reserves and IBNR loss reserves, until the occurrence of an event which may give rise to a claim. As a result, only loss reserves applicable to losses incurred up to the reporting date are established, with no allowance for the establishment of loss reserves to account for expected future loss events.

 

Generally, the Company obtains regular updates of premium and loss related information for the current and historical periods, which are utilized to update the initial expected loss ratio. We also experience a lag between (i) claims being reported by the underlying insured to the Company’s cedent and (ii) claims being reported by the Company’s cedent to the Company. This lag may impact the Company’s loss reserve estimates. Client reports have pre-determined due dates (for example, thirty days after each month end). As a result, the lag depends in part upon the terms of the specific contract. The timing of the reporting requirements is designed so that the Company receives premium and loss information as soon as practicable once the client has closed its books. Accordingly, there should be a short lag in such reporting. Additionally, most of the contracts that have the potential for large single event losses have provisions that such loss notifications are provided to the Company immediately upon the occurrence of an event.

 

Stock-Based Compensation

 

The Company has accounted for stock-based compensation under the provisions of ASC Topic 718 – Stock Compensation which requires the use of the fair-value based method to determine compensation for all arrangements under which employees and others receive shares of stock or equity instruments. The fair value of each stock option award is estimated on the date of grant using the Black-Scholes valuation model using assumptions for expected volatility, expected dividends, expected term, and the risk-free interest rate along with multiple Monte Carlo simulations to determine a derived service period as the options vest based upon meeting certain performance conditions. The fair value of each stock option award is recorded as compensation expense on a straight-line basis over the requisite service period, which is generally the period in which the stock options vest, with a corresponding increase to additional paid-in capital.

 

12

 

 

The Company has also issued restricted stock units (“RSUs”) to certain of its employees and directors which have been accounted for as equity-based awards since, upon vesting, they are required to be settled in the Company’s common shares. We have used the fair value of the Company’s common stock on the date the RSUs were issued to estimate the grant date fair value of those RSUs which vest solely based upon the passage of time, as well as a Monte Carlo valuation model to estimate the fair value of those RSUs which vest solely upon market-based conditions. The fair value of each RSU is recorded as compensation expense over the requisite service period, which is generally the expected period over which the awards will vest. In the case of those RSUs which vest upon market-based conditions, should the market-based condition be achieved prior to the expiration of the derived service period, any unrecognized cost will be recorded as compensation expense in the period in which the RSUs actually vest.

 

Based upon the Company’s historical forfeiture rates relating to stock options and RSUs, the Company has not made any adjustment to stock compensation expense for expected forfeitures as of March 31, 2023.

 

Fair Value of Financial Instruments

 

The carrying values of certain financial instruments, including cash, short-term investments, deposits held, accounts payable, and other accrued expenses approximate fair value due to their short-term nature. The Company measures the fair value of financial instruments in accordance with GAAP which defines fair value as the exchange price that would be received for an asset (or paid to transfer a liability) in the principal or most advantageous market for the asset (or liability) in an orderly transaction between market participants on the measurement date. GAAP also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. See Note 4 for further information on the fair value of the Company’s financial instruments.

 

Earnings (Loss) Per Common Share

 

Basic earnings (loss) per common share is computed using the weighted average number of shares outstanding during the respective period.

 

Diluted earnings (loss) per common share assumes conversion of all potentially dilutive outstanding stock options, restricted stock units, warrants or other convertible financial instruments. Potential common shares outstanding are excluded from the calculation of diluted earnings (loss) per share if their effect is anti-dilutive.

 

Note 3. Recently Adopted and Issued Accounting Standards

 

As discussed above, the Company adopted ASU 2016-13 during the first quarter of 2023 using a modified retrospective transition method. The adoption resulted in a cumulative-effect adjustment to increases accumulated deficit by $0.1 million as of January 1, 2023.

 

Note 4. Investments and Fair Value Disclosures

 

The following table summarizes the Company’s investments held at fair value as of December 31, 2022.

 

(in thousands)

 

As of December 31, 2022   Cost Basis    

Gross

Unrealized

Gains

   

Gross

Unrealized

Losses

   

Carrying

Amount

 
Hagerty common stock   $ 889     $     $ 48     $ 841  
Total investments   $ 889     $     $ 48     $ 841  

 

13

 

 

Hagerty Common Stock

 

On December 15, 2022, FGMP distributed 99,999 common shares of Hagerty to the Company. On the date of distribution, the common shares had an aggregate fair value of approximately $889,000. The Company sold the common shares during the first quarter of 2023 for a realized loss of approximately $16,000.

 

Equity Method Investments

 

Other investments on the Company’s Consolidated Balance Sheets includes our equity method investments in FGMP and the Fund.

 

On January 4, 2021, FGMP was formed as a Delaware limited partnership to co-sponsor newly formed SPACs with their founders or partners, as well as other merchant banking interests. The Company is the sole managing member of the general partner of FGMP and holds a limited partner interest of approximately 48% in FGMP directly and through its subsidiaries. FGMP participates as a co-sponsor of the SPACs launched under our SPAC Platform as well as merchant banking initiatives. For the three months ended March 31, 2023, the Company has contributed $0.1 million into FGMP. The Company has recorded equity method gains from FGMP of approximately $3.1 million for the three months ended March 31, 2023. The carrying value of our investment in FGMP as of March 31, 2023 was approximately $8.9 million compared to $5.7 million as of December 31, 2022. Of the $9.0 million carrying value of our investment in FGMP at March 31, 2023 the Company may allocate up to approximately $1.0 million to incentivize and compensate individuals and entities for the successful merger of SPAC’s launched under our platform.

 

Equity method investments also include our investment in the Fund, in which we hold an approximately 61% limited partner interest as of March 31, 2023. For the three months ended March 31, 2023, the Company has received cash distributions in the approximate amount of $0.8 million. The Company has recorded equity method losses from the Fund of approximately $0.3 million for the three months ended March 31, 2023. As of March 31, 2023, the carrying value of our investment in the Fund was approximately $15.7 million, compared to $16.8 million as of December 31, 2022.

 

Financial information for our investments accounted for under the equity method, in the aggregate, is as follows:

 

  

As of March 31,

2023

  

As of December 31,

2022

 
(in thousands)        
Other investments  $42,782   $35,366 
Cash   174    113 
Other assets   148    165 
Total assets   43,104    35,644 
           
Accounts payable  $331   $65 
Due to Investor   24,460      
Total liabilities   24,791    65 

 

14

 

 

   Three months ended March 31, 2023   Three months ended March 31, 2022 
(in thousands)        
Net investment income (loss)  $5,872   $(3,455)
General and administrative expenses   (250)   (73)
Net income (loss)   5,622    (3,528)

 

Certain investments held by our equity method investees are valued using Monte-Carlo simulation and option pricing models. Inherent in Monte-Carlo simulation and option pricing models are assumptions related to expected volatility and discount for lack of marketability of the underlying investment. Our investees estimate the volatility of these investments based on the historical performance of various broad market indices blended with various peer companies which they consider as having similar characteristics to the underlying investment, as well as consideration of price and volatility of relevant publicly traded securities such as SPAC warrants. Our investees also consider the probability of a successful merger when valuing SPAC equity.

 

During the first quarter of 2023, it was determined that the Fund would begin the process of winding down. All investment holdings currently held in the name of the Fund will be transferred or distributed to members within the fund based on their ownership percentage of each respective holding. As previously discussed, the Fund currently accounts for its investment holdings at fair value, and the Company expects to continue to hold the investments at fair value subsequent to the transfer. The process is expected to be completed sometime during the second quarter of 2023. The Company does not expect any impact to shareholders’ equity as a result of the Fund winding down.

 

Investments without Readily Determinable Fair Value

 

In addition to our equity method investments, other investments, as listed on our Consolidated Balance Sheets, consists of equity we have purchased in companies for which there does not exist a readily determinable fair value. This includes the Company’s $2.0 million direct investment in FGC. The Company accounts for these investments at their cost, subject to any adjustment from time to time due to impairment or observable price changes in orderly transactions. Any profit distributions the Company receives on these investments are included in net investment income. The Company’s total investment in companies without a readily determinable fair value was approximately $2.2 million as of March 31, 2023, compared to approximately $2.3 million as of December 31, 2022.

 

For the three months ended March 31, 2023 the Company has received distributions of approximately $35,000.

 

Other

 

Other investments, in addition to equity method investments and investments without readily determinable fair value, include a convertible promissory note and a senior unsecured promissory note. On March 15, 2023, the Company invested $500,000 in a convertible promissory note with iCore. The promissory note has an interest rate of 15% annually, with interest payments due monthly, and matures on March 15, 2024. Beginning September 15, 2023, the Company has the option to convert any unpaid loan amount and all accrued and unpaid interest into fully paid shares of iCore common stock, at a conversion price of $0.10 per share. The Company evaluated the convertible promissory note’s settlement provisions and elected the fair value option to value this instrument. Under the fair value election, the convertible promissory note is measured initially and subsequently at fair value, which as of March 31, 2023, represents the original invested amount of $500,000. Any changes in the fair value of the instrument in future periods will be recorded in the consolidated statements of operations as a change in fair value. On March 16, 2023, the Company invested $200,000 in a senior unsecured loan to Craveworthy. The loan has an interest rate of 13% and a maturity of March 15, 2024. The $200,000 principal and any interest accrued may be prepaid voluntarily by Craveworthy, but is not required to be done until the date of maturity.

 

Interest accrued or received on notes are included in net investment income. The Company had a balance of $0.7 million related to notes receivable included in other investments as of March 31, 2023, compared to zero as of December 31, 2022.

 

Impairment

 

For equity securities without readily determinable fair values, impairment is determined via a qualitative assessment which considers indicators to evaluate whether the investment is impaired. Some of these indicators include a significant deterioration in the earnings performance or asset quality of the investee, a significant adverse change in regulatory, economic or general market conditions in which the investee operates, or doubt over an investee’s ability to continue as a going concern. If the investment is deemed to be impaired after conducting this analysis, the Company would estimate the fair value of the investment to determine the amount of impairment loss.

 

For equity method investments, such as the Company’s investments in FGMP and the Fund, evidence of a loss in value might include a series of operating losses of an investee, the absence of an ability to recover the carrying amount of the investment, or a deterioration in the value of the investee’s underlying assets. If these, or other indicators lead to the conclusion that there is a decrease in the value of the investment that is other than temporary, the Company would recognize that decrease in value even though the decrease may be in excess of what would otherwise be recognized under the equity method of accounting.

 

15

 

 

The risks and uncertainties inherent in the assessment methodology used to determine impairment include, but may not be limited to, the following:

 

  the opinions of professional investment managers and appraisers could be incorrect;
     
  the past operating performance and cash flows generated from the investee’s operations may not reflect their future performance; and
     
  the estimated fair values for investment for which observable market prices are not available are inherently imprecise.

 

We have not recorded an impairment on our investments for either of the quarters ended March 31, 2023 and 2022.

 

Net investment income (loss) for the quarters ended March 31, 2023 and 2022 is as follows:

   2023   2022 
(in thousands)  Three months ended March 31, 
   2023   2022 
Investment income (loss):          
Realized loss on FedNat common stock  $-   $(2,877)
Change in unrealized holding loss on FedNat common stock   -    2,774 
Realized loss on Hagerty common stock   (16)   - 
Change in unrealized holding loss on Hagerty common stock   48    - 
Equity method earnings (losses)   2,680    (2,071)
Other income (loss)   128    (172)
Net investment income (loss)  $2,840   $(2,346)

 

Fair Value Measurements

 

The Company determines fair value based on assumptions that market participants would use in pricing an asset or liability in the principal or most advantageous market. The FASB has issued guidance that defines fair value as the exchange price that would be received for an asset (or paid to transfer a liability) in the principal, or most advantageous market in an orderly transaction between market participants. This guidance also establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The guidance categorizes assets and liabilities at fair value into one of three different levels depending on the observation of the inputs employed in the measurements, as follows:

 

  Level 1 – inputs to the valuation methodology are quoted prices for identical assets or liabilities in active markets providing the most reliable measurement of fair value since it is directly observable.
     
  Level 2 – inputs to the valuation methodology which include quoted prices for similar assets or liabilities in active markets. These inputs are observable, either directly or indirectly, for substantially the full-term of the financial instrument.
     
  Level 3 - inputs to the valuation methodology which are unobservable and significant to the measurement of fair value.

 

The availability of valuation techniques and observable inputs can vary from investment to investment and are affected by a variety of factors, including the type of investment, whether the investment is new and not yet established in the marketplace, the liquidity of markets and other characteristics specific to the individual investment. In some cases, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the hierarchy based on the lowest level input that is significant to the fair value measurement. When determining fair value, the Company uses valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs.

 

16

 

 

Financial instruments measured, on a recurring basis, at fair value as December 31, 2022 in accordance with the guidance promulgated by the FASB are as follows.

(in thousands)                
                 
As of December 31, 2022                    
Hagerty common stock  $841   $   $   $841 
   $841   $   $   $841 

 

Note 5. Loss and Loss Adjustment Expense Reserves

 

A significant degree of judgment is required to determine amounts recorded in the consolidated financial statements for the provision for loss and loss adjustment expense (“LAE”) reserves. The process for establishing this provision reflects the uncertainties and significant judgmental factors inherent in predicting future results of both known and unknown loss events. The process of establishing the provision for loss and LAE reserves relies on the judgment and opinions of many individuals, including the opinions of the Company’s management, as well as the management of ceding companies and their actuaries.

 

In estimating losses, the Company may assess any of the following:

 

  a review of in-force treaties that may provide coverage and incur losses;
     
  general forecasts, catastrophe and scenario modelling analyses and results shared by cedents;
     
  reviews of industry insured loss estimates and market share analyses;
     
  management’s judgement; and
     
  loss development factor selections, initial expected loss ratio selections, and weighting of methods used

 

Under the terms of certain of our quota-share agreements, and due to the nature of claims and premium reporting, a lag exists between (i) claims being reported by the underlying insured to the Company’s cedent and (ii) claims being reported by the Company’s cedent to the Company. This lag may impact the Company’s loss reserve estimates. The reports we receive from our cedents have pre-determined due dates. In the case of the Company’s FAL contract, first quarter 2023 premium and loss information will not be made available to the Company until subsequent to the filing of this quarterly report. Thus, our first quarter results, including the loss and loss adjustment expense reserves presented herein, have been based upon a combination of actual results from the 2022 calendar year as well as forecasts for 2023 reported to us by the ceding companies. We have approximated first quarter 2023 results under our contracts based upon this historical and forecasted information.

 

While the Company believes its estimate of loss and loss adjustment expense reserves are adequate as of March 31, 2023, based on available information, actual losses may ultimately differ materially from the Company’s current estimates. The Company will continue to monitor the appropriateness of its assumptions as new information is provided.

 

17

 

 

A summary of changes in outstanding loss and loss adjustment expense reserves for the quarters ended March 31, 2023 and 2022, is as follows:

 

(in thousands)  2023   2022 
         
Balance, January 1   4,409    2,133 
Incurred related to:          
Current year   1,616    732 
Prior years   301    791 
Paid related to:          
Current year   (1,797)   (1,026)
Prior years   (485)   (675)
Balance, March 31   4,044    1,955 

 

Note 6. Income Taxes

 

Actual income tax expense (benefit) differs from the income tax expense computed by applying the applicable effective federal and state tax rates to income before income tax expense as follows:

 

($ in thousands)  Three months ended March 31, 
   2023   2022 
   Amount   %   Amount   % 
                 
Provision for taxes at U.S. statutory marginal income tax rate of 21%  $284    21.0%  $(803)   21.0%
Valuation allowance for deferred tax assets deemed unrealizable   (284)   (21.0)%   798    (20.9)%
Share-based compensation   -     %   5    (0.1)%
Income tax benefit  $    %  $-    -%

 

Deferred income taxes reflect the net tax effects of temporary differences between carrying amounts of assets and liabilities for financial reporting purposes as compared to the amounts used for income tax purposes. The Company’s gross deferred tax assets and liabilities are $9.1 million and $4.0 million as of March 31, 2023. The Company has recorded a valuation allowance against its deferred tax assets of $5.2 million, as of March 31, 2023, due to the uncertain nature surrounding our ability to realize these tax benefits in the future. Significant components of the Company’s net deferred tax assets are as follows:

 

           
(in thousands)    
  

As of March 31,

2023

  

As of December 31,

2022

 
Deferred income tax assets:          
Net operating loss carryforward  $4,339   $4,171 
Loss and loss adjustment expense reserves   36    39 
Unearned premium reserves   274    287 
Capital loss carryforward   4,157    4,313 
Share-based compensation   294    242 
Investments   5    5 
Other   36    9 
Deferred income tax assets  $9,141   $9,066 
Less: Valuation allowance   (5,179)   (5,463)
Deferred income tax assets net of valuation allowance  $3,962   $3,603 
           
Deferred income tax liabilities:          
Investments  $267   $3,282 
Deferred policy acquisition costs   3,695    321 
Deferred income tax liabilities  $3,962   $3,603 
           
Net deferred income tax asset (liability)  $   $ 

 

18

 

 

As of March 31, 2023, the Company had net operating loss carryforwards (“NOLs”) for federal income tax purposes of approximately $20.7 million, which will be available to offset future taxable income. Approximately $0.5 million expires on December 31, 2039, $0.1 million expires on December 31, 2040, and $1.6 million of the Company’s NOLs will expire on December 31, 2041. The remaining $18.4 million of the Company’s NOLs do not expire under current tax law. Additionally, the Company has approximately $19.8 million of capital loss carryforward that can only be used to offset capital gains and which will expire in December 2026 if not used prior.

 

As of March 31, 2023, the Company had no unrecognized tax benefits. The Company analyzed its tax positions in accordance with the provisions of Accounting Standards Codification Topic 740, Income Taxes, and has determined that there are currently no uncertain tax positions. The Company generally recognizes interest and penalties, if any, related to unrecognized tax benefits in income tax expense.

 

Note 7. Equity Incentive Plan Grants

 

On December 15, 2021, our shareholders approved the FG Financial Group, Inc. 2021 Equity Incentive Plan (the “2021 Plan”). The purpose of the 2021 Plan is to attract and retain directors, consultants, officers and other key employees of the Company and its subsidiaries and to provide to such persons incentives and rewards for superior performance. The 2021 Plan is administered by the Compensation and Management Resources Committee of the Board and has a term of ten years. The 2021 Plan awards may be in the form of stock options (which may be incentive stock options or nonqualified stock options), stock appreciation rights (or “SARs”), restricted shares, restricted share units, and other share-based awards, and provides for a maximum of 1,500,000 shares available for issuance.

 

On March 24, 2023, the Company’s board of directors approved an amendment to the 2021 Plan to increase the number of shares available for issuance from 1,500,000 to 2,000,000.

 

As of March 31, 2023, the Company had 901,970 RSUs outstanding and 130,000 non-qualified stock options outstanding under its equity incentive plans.

 

RSUs Outstanding

 

The following table summarizes RSU activity for the three months ended March 31, 2023 and 2022:

 

Restricted Stock Units  Number of Units  

Weighted

Average Grant Date Fair Value

 
Non-vested units, January 1, 2023   256,382   $2.57 
Granted   785,000    2.80 
Vested (1)   (139,412)   2.82 
Forfeited        
Non-vested units, March 31, 2023   901,970   $2.73 
           
Non-vested units, January 1, 2022   164,655   $4.35 
Granted        
Vested   (30,796)   4.45 
Forfeited        
Non-vested units, March 31, 2022   133,859   $4.33 

 

  (1) Includes 131,080 of vested shares that have not been issued.

 

19

 

 

On August 19, 2022, we issued a total of 158,225 RSUs to our non-employee directors. The RSUs vest in five equal annual installments, beginning with the first anniversary of the grant date.

 

On February 17, 2023, we granted a total of 415,000 RSUs to various members of the Company’s management. The RSUs vest in three equal annual installments, beginning with the date the shares were granted.

 

On January 18, 2021, the Company entered into an Equity Award Letter Agreement (the “Letter Agreement”) with Mr. Swets, pursuant to which the Company clarified its intention to grant an additional 370,000 stock options, restricted shares or restricted stock units pursuant to a future award, subject to the approval of an amended and/or new equity plan, among other conditions. On February 17, 2023, in satisfaction of the obligations in the letter agreement, the Company granted 370,000 RSU’s to Mr. Swets that will vest on the first anniversary of the grant date.

 

Restricted Shares

 

On July 31, 2022, the Company issued 25,000 restricted shares under the 2021 Equity Incentive Plan to an employee of the Company. The restriction will be lifted on the first anniversary of the grant date.

 

Stock Options Outstanding

 

On January 12, 2021, in connection with Larry G. Swets, Jr.’s appointment as Chief Executive Officer, the Company entered into a Stock Option Agreement (the “Stock Option”) with Mr. Swets. The Stock Option entitles Mr. Swets to purchase up to 130,000 shares of the Company’s common stock at an exercise price of $3.38 per share. The Stock Option becomes vested and fully exercisable in 20% increments on each anniversary of the grant date, provided that Mr. Swets remains in the continuous service of the Company through each applicable vesting date and that the Company’s book value per share has increased by 15% or more as compared to the Company’s book value per share as of the fiscal year end prior. The Stock Option expires on January 11, 2031.

 

The Stock Option contains performance and service conditions that affect vesting. Pursuant to ASC Topic 718- Stock Compensation, these conditions have not been reflected in estimating the fair value of the award upon its grant date; however, the Company employed a Monte-Carlo model to estimate the likelihood of satisfaction of the required performance and service conditions. This resulted in a derived service period of approximately 3.3 years under the grant.

 

In estimating the fair value of the Stock Option, the Company estimated volatility based on the historical volatility of our stock. The risk-free interest rate is based on the U.S. Treasury Constant Maturity similar to the expected remaining life of the Stock Option. The expected life of the Stock Option is assumed to be equivalent to its contractual term. The dividend rate is based on our historical rate, which the Company anticipates will remain at zero. The following assumptions were used to determine the estimated fair value of the Stock Option:

 

Expected volatility   45.60%
Expected life (years)   10.00 
Risk-free interest rate   1.15%
Dividend yield   0.00%

 

20

 

 

The following table summarizes activity for stock options issued for the quarters ended March 31, 2023 and 2022:

 

Common Stock Options  Shares   Weighted Ave Exercise Price   Weighted Ave Remaining Contractual Term (yrs)   Weighted Ave Grant Date Fair Value   Aggregate Intrinsic Value 
Outstanding, January 1, 2023   130,000   $3.38    8.04   $1.88   $- 
Exercisable, January 1, 2023      $       $   $ 
Granted                    
Exercised                    
Cancelled                    
Outstanding, March 31, 2023   130,000   $3.38    7.79   $1.88   $- 
Exercisable, March 31, 2023      $       $   $ 
                          
Outstanding, January 1, 2022   130,000   $3.38    9.04   $1.88   $49,400 
Exercisable, January 1, 2022      $       $   $ 
Granted    _   -    -    -     
Exercised                    
Cancelled                    
Outstanding, March 31, 2022   130,000   $3.38    8.79   $1.88   $(85,100)
Exercisable, March 31, 2022      $       $   $ 

 

Total stock-based compensation expense for the three months ended March 31, 2023 and 2022 was approximately $641,000 and $62,000, respectively. As of March 31, 2023, total unrecognized stock compensation expense of $2.2 million remains, which will be recognized through December 31, 2026. Stock compensation expense has been reflected in the Company’s financial statements as part of general and administrative expense.

 

Warrants

 

No warrants were granted or exercised during the quarters ended March 31, 2023 and 2022. On February 24, 2022, 1,500,000 warrants with an exercise price of $15.00 expired. As of March 31, 2023, the Company did not have any warrants outstanding.

 

Note 8. Related Party Transactions

 

Related party transactions are carried out in the normal course of operations and are measured in part by the amount of consideration paid or received, as established and agreed by the parties. Management believes that consideration paid for such services in each case approximates fair value. Except where disclosed elsewhere in these consolidated financial statements, the following is a summary of related party transactions.

 

Joint Venture Agreement

 

On March 31, 2020, the Company entered into the Limited Liability Company Agreement of Fundamental Global Asset Management, LLC (“FGAM”), a newly-formed joint venture owned 50% by each of the Company and FG. The purpose of FGAM is to sponsor, capitalize and provide strategic advice to investment managers in connection with the launch and/or growth of their asset management businesses and the investment products they sponsor (each, a “Sponsored Fund”).

 

21

 

 

FGAM is governed by a Board of Managers consisting of four managers, two of which have been appointed by each Member. The Company has appointed two of its independent directors to the Board of Managers of FGAM. Certain major actions, including any decision to sponsor a new investment manager, require the prior consent of both Members.

 

FG Special Situations Fund

 

The Company participates as a limited partner in the Fund. The general partner of the Fund, and the investment advisor of the Fund, are ultimately controlled by Mr. Cerminara, the Chairman of the Company’s Board of Directors. Portions of the Company’s investment into the Fund were used to sponsor the launch of SPACs affiliated with certain of our officers and directors.

 

Mr. Cerminara, our chairman, and Mr. Swets, our Chief Executive Officer and Director, are managers of the sponsor company of FG New America Acquisition Corp (“FGNA”). Mr. Cerminara, Mr. Swets and Mr. Baqar, our Executive Vice President and Chief Financial Officer, serve as managers of the sponsor companies of FG Merger and FG Acquisition. Until FGNA’s business combination with OppFi (NYSE: OPFI), Mr. Swets was the Chief Executive Officer and a Director of FGNA, Mr. Cerminara was a Director of FGNA, and Mr. Baqar was the Chief Financial Officer of FGNA. Until Aldel’s business combination with Hagerty, Mr. Swets served as Senior Advisor to Aldel, Mr. Baqar served as Chief Financial Officer of Aldel, and Mr. Cerminara served as a Director of Aldel. Messrs. Cerminara, Swets, and Baqar also hold financial interests in the SPACs and/or their sponsor companies. Mr. Swets serves as Chairman of FG Merger, while Messrs. Baqar and Cerminara serve as Director and Senior Advisor of FG Merger, respectively. Mr. Swets serves as Chief Executive Officer and Director of FG Acquisition. Mr. Baqar serves as Chief Financial Officer, Secretary and Director of FG Acquisition. Mr. Cerminara serves as Chairman of FG Acquisition.

 

FG Merchant Partners

 

FGMP was formed to co-sponsor newly formed SPACs with their founders or partners. The Company is the sole managing member of the general partner of FGMP and holds a limited partner interest in FGMP. Certain of our directors and officers also hold limited partner interests in FGMP. Mr. Swets holds a limited partner interest through Itasca Financial LLC, an advisory and investment firm for which Mr. Swets is managing member. Mr. Baqar also holds a limited partner interest through Sequoia Financial LLC, an advisory firm for which Mr. Baqar is managing member. Mr. Cerminara also holds a limited partner interest through Fundamental Global, LLC, a holding company for which Mr. Cerminara is the manager and one of the members.

 

FGMP has invested in the founder shares and warrants of Aldel, FG Merger Corp, FG Acquisition Corp, FGC and Craveworthy. Certain of our directors and officers are affiliated with these entities and their sponsor companies as described above.

 

FG Communities

 

In October of 2022, the Company directly invested $2.0 million into FGC. The Company also holds an interest through its ownership in FGMP. FGC is a self-managed real estate company focused on a growing portfolio of manufactured housing communities which are owned and operated by FGC. Mr. Cerminara is the President and a director of FGC.

 

iCoreConnect

 

On March 15, 2023, the Company invested $500,000 in a convertible promissory note to support FG Merger Corp’s transaction with iCore. FGMP owns underlying securities of FG Merger Corp. In addition, Mr. Cerminara, Mr. Swets and Mr. Baqar each invested separately in the same convertible promissory note.

 

22

 

 

Craveworthy

 

On March 16, 2023, the Company invested $200,000 in a senior unsecured loan to Craveworthy. Mr. Swets has an indirect interest in Craveworthy, independent from the interests held by the Company through its ownership in FGMP.

 

Shared Services Agreement

 

On March 31, 2020, the Company entered into a Shared Services Agreement (the “Shared Services Agreement”) with Fundamental Global Management, LLC (“FGM”), an affiliate of FG, pursuant to which FGM provides the Company with certain services related to the day-to-day management of the Company, including assisting with regulatory compliance, evaluating the Company’s financial and operational performance, providing a management team to supplement the executive officers of the Company, and such other services consistent with those customarily performed by executive officers and employees of a public company. In exchange for these services, the Company pays FGM a fee of $456,000 per quarter (the “Shared Services Fee”), plus reimbursement of expenses incurred by FGM in connection with the performance of the Services, subject to certain limitations approved by the Company’s Board of Directors or Compensation Committee from time to time.

 

The Shared Services Agreement has an initial term of three years, and thereafter renews automatically for successive one-year terms unless terminated in accordance with its terms. The Shared Services Agreement may be terminated by FGM or by the Company, by a vote of the Company’s independent directors, at the end of the initial or automatic renewal term upon 120 days’ notice, subject to payment by the Company of certain costs incurred by FGM to wind down the provision of services and, in the case of a termination by the Company without cause, payment of a termination fee equal to the Shared Services Fee paid for the two quarters preceding termination.

 

The Company paid $456,250 and $457,000 to FGM under the Shared Services Agreement for each of the three months ended March 31, 2023 and 2022, respectively.

 

Note 9. Net Earnings Per Share

 

Net earnings per share is computed by dividing net income by the weighted average number of common shares and common share equivalents outstanding during the periods presented. In calculating diluted earnings per share, those potential common shares that are found to be anti-dilutive are excluded from the calculation. The table below provides a summary of the numerators and denominators used in determining basic and diluted earnings per share for the three months ended March 31, 2023 and 2022.

 

   2023   2022 
($ in thousands, except per share data)  Three months ended March 31, 
   2023   2022 
Basic and diluted:          
Net income (loss)  $1,350   $(3,823)
Dividends declared on Series A Preferred Shares   (447)   (447)
Income (loss) attributable to FG Financial Group, Inc. common shareholders    903    (4,270)
Weighted average common shares   9,421,993    6,477,568 
Income (loss) per common share   $0.10   $(0.66)
Income (loss) per share attributable to common shareholders  $0.10   $(0.66)

 

23

 

 

The following potentially dilutive securities outstanding as of March 31, 2023 and 2022 have been excluded from the computation of diluted weighted-average shares outstanding as their effect would be anti-dilutive.

 

   As of March 31, 
   2023   2022 
Warrants to purchase common stock   -    - 
Options to purchase common stock   130,000    130,000 
Restricted stock units   901,970    133,859 
    1,031,970    263,859 

 

Note 10. Commitments and Contingencies

 

Legal Proceedings:

 

As of March 31, 2023, the Company was not aware of any material claims or actions pending or threatened against us. From time to time, we are involved in legal proceedings and litigation arising in the ordinary course of business. Currently, it is not possible to predict legal outcomes and their impact on the future development of claims. Any such development will be affected by future court decisions and interpretations. Because of these uncertainties, additional liabilities may arise for amounts in excess of the Company’s current reserves.

 

Operating Lease Commitments:

 

In July 2021, the Company entered into a lease agreement for office space in St. Petersburg, FL. The lease had a term of 12 months and was not renewed upon expiration. Total minimum rent over the 12-month term was approximately $17,000. Due to the short-term nature of the lease, the Company recognized lease expense on a straight-line basis over the term of the lease, with any variable lease payments recognized in the period in which the obligation for the payment occurred. Rent expense related to the St. Petersburg office was zero and approximately $5,000 for the three months ended March 31, 2023 and March 31, 2022, respectively.

 

In April 2022, the Company entered into a lease agreement for office space in Itasca, IL. The lease has a term of 44 months beginning on May 1, 2022. Total minimum rent over the term of the lease is expected to be approximately $77,000. The Company has accounted for the lease under ASC 842, Leases. The annual discount rate used for the Itasca office was 8%. As of March 31, 2023, the right of use asset and lease liability are approximately $52,000, each, and held in “Other assets” and “Other liabilities” on the balance sheet, respectively. Rent expense related to the Itasca office was approximately $5,000 and zero for the three months ended March 31, 2023 and March 31, 2022, respectively.

 

Impact of Russian/Ukraine Conflict

 

Management is currently evaluating the impact of rising interest rates, inflation and the Russia-Ukraine war and has concluded that while it is reasonably possible that any of these could have a negative effect on the Company’s financial position and results of its operations, the specific impact is not readily determinable as of the date of these unaudited consolidated financial statements. The unaudited consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

Note 11. Segment Reporting

 

The Company has two operating segments—insurance and asset management. The chief operating decision maker (“CODM”) is the Company’s Chief Executive Officer. The measure of profit or loss used by the CODM to identify and measure the Company’s reportable segments is income before income tax. Our insurance segment consists of the operations of our Cayman Islands-based reinsurance subsidiary, FGRe, as well as the returns associated with the investments made by our reinsurance operations. Our asset management segment includes our investments made outside of reinsurance operations.

 

The following table presents the financial information for each segment that is specifically identifiable or based on allocations using internal methodology as of and for the three months ended March 31, 2023 and 2022. The ‘other’ category in the table below consists largely of corporate general and administrative expenses which have not been allocated to a specific segment. Segment assets for the “other” category primarily consist of unrestricted cash in the amounts of $3.2 million and $6.7 million as of March 31, 2023 and 2022, respectively.

 

24

 

 

(in thousands)                
                 
For the three months ended March 31, 2023  Insurance   Asset Management   Other   Total 
Net premiums earned  $3,657   $   $   $3,657 
Net investment income (loss)   3,269    (429)   _   2,840 
Other income   _   30        30 
Total revenue   6,926    (399)       6,527 
Income (loss) before income tax   3,926    (400)   (2,176)   1,350 
                     
As of March 31, 2023                    
Segment assets  $27,919   $18,346   $3,739   $50,004 
                     
For the three months ended March 31, 2022                    
Net premiums earned  $2,473   $   $   $2,473 
Net investment (loss)   (969)   (1,377)       (2,346)
Other income       25        25 
Total revenue   1,504    (1,352)       152 
Income (loss) before income tax   (661)   (1,562)   (1,600)   (3,823)
                     
As of March 31, 2022                    
Segment assets  $11,955   $13,365   $10,284   $35,644 

 

Note 12. Subsequent Events

 

The Corporation has evaluated subsequent events through the filing date of the financial statements and determined that there have been no events that have occurred that would require additional disclosures.

 

25

 

 

FG FINANCIAL GROUP, INC.

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

You should read the following discussion in conjunction with our consolidated financial statements and related notes and information included elsewhere in this Quarterly Report on Form 10-Q and in our Annual Report for the year ended December 31, 2022 on Form 10-K filed with the Securities and Exchange Commission (“SEC”) on March 24, 2023.

 

Unless context denotes otherwise, the terms “Company,” “FGF,” “we,” “us,” and “our,” refer to FG Financial Group, Inc., and its subsidiaries.

 

Cautionary Note about Forward-Looking Statements

 

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). These statements are therefore entitled to the protection of the safe harbor provisions of these laws. These statements may be identified by the use of forward-looking terminology such as “anticipate,” “believe,” “budget,” “can,” “contemplate,” “continue,” “could,” “envision,” “estimate,” “expect,” “evaluate,” “forecast,” “goal,” “guidance,” “indicate,” “intend,” “likely,” “may,” “might,” “outlook,” “plan,” “possibly,” “potential,” “predict,” “probable,” “probably,” “pro-forma,” “project,” “seek,” “should,” “target,” “view,” “will,” “would,” “will be,” “will continue,” “will likely result” or the negative thereof or other variations thereon or comparable terminology. In particular, discussions and statements regarding the Company’s future business plans and initiatives are forward-looking in nature. We have based these forward-looking statements on our current expectations, assumptions, estimates, and projections. While we believe these to be reasonable, such forward-looking statements are only predictions and involve a number of risks and uncertainties, many of which are beyond our control. These and other important factors may cause our actual results, performance, or achievements to differ materially from any future results, performance or achievements expressed or implied by these forward-looking statements, and may impact our ability to implement and execute on our future business plans and initiatives.

 

Management cautions that the forward-looking statements in this Quarterly Report on Form 10-Q are not guarantees of future performance, and we cannot assume that such statements will be realized or the forward-looking events and circumstances will occur. Factors that might cause such a difference include, without limitation: general conditions in the global economy; our lack of operating history or established reputation in the reinsurance industry; our inability to obtain or maintain the necessary approvals to operate reinsurance subsidiaries; risks associated with operating in the reinsurance industry, including inadequately priced insured risks, credit risk associated with brokers we may do business with, and inadequate retrocessional coverage; our inability to execute on our investment and investment management strategy, including our strategy to invest in the risk capital of special purpose acquisition companies (SPACs); potential loss of value of investments; risk of becoming an investment company; fluctuations in our short-term results as we implement our new business strategy; risks of being unable to attract and retain qualified management and personnel to implement and execute on our business and growth strategy; failure of our information technology systems, data breaches and cyber-attacks; our ability to establish and maintain an effective system of internal controls; our limited operating history as a public company; the requirements of being a public company and losing our status as a smaller reporting company or becoming an accelerated filer; any potential conflicts of interest between us and our controlling stockholders and different interests of controlling stockholders; potential conflicts of interest between us and our directors and executive officers; risks associated with our related party transactions and investments; and risks associated with our investments in SPAC, including the failure of any such SPAC to complete its initial business combination. Our expectations and future plans and initiatives may not be realized. If one of these risks or uncertainties materializes, or if our underlying assumptions prove incorrect, actual results may vary materially from those expected, estimated or projected. You are cautioned not to place undue reliance on forward-looking statements. The forward-looking statements are made only as of the date hereof and do not necessarily reflect our outlook at any other point in time. We do not undertake and specifically decline any obligation to update any such statements or to publicly announce the results of any revisions to any such statements to reflect new information, future events or developments.

 

26

 

 

Overview

 

FG Financial Group, Inc. (“FGF”, the “Company”, “we”, or “us”) is a reinsurance, merchant banking and asset management holding company. We focus on opportunistic collateralized and loss-capped reinsurance, while allocating capital in partnership with Fundamental Global®, and from time to time, other strategic investors, to merchant banking activities. The Company’s principal business operations are conducted through its subsidiaries and affiliates. From our inception in October 2012 through December 2019, we operated as an insurance holding company, writing property and casualty insurance throughout the states of Louisiana, Florida, and Texas. On December 2, 2019, we sold our three former insurance subsidiaries, and embarked upon our current strategy focused on reinsurance, merchant banking and asset management.

 

As of March 31, 2023, FG Financial Holdings, LLC (“FG”), a private partnership focused on long-term strategic holdings, and its affiliated entity collectively beneficially owned approximately 60.0% of our common stock. D. Kyle Cerminara, Chairman of our Board of Directors, serves as Chief Executive Officer, Co-Founder and Partner of FG.

 

Sale of Insurance Business

 

On December 2, 2019, we completed the sale (“Asset Sale”) of our insurance subsidiaries to FedNat Holding Company for a combination of cash and FedNat common stock. The Company sold its remaining FedNat common stock shares held in October 2022.

 

Critical Accounting Estimates

 

Critical accounting estimates are those estimates made in accordance with generally accepted accounting principles that involve a significant level of estimation uncertainty and have had or are reasonably likely to have a material impact on our financial condition or results of operations. Actual results may differ materially from these estimates. Set forth below is qualitative and quantitative information necessary to understand the estimation uncertainty and the impact the critical accounting estimate has had or is reasonably likely to have on financial condition or results of operations, to the extent the information is material and reasonably available.

 

Other Investments

 

Other investments consist, in part, of equity investments made in privately held companies accounted for under the equity method. As discussed further in Note 4, certain investments held by our equity method investees are valued using Monte-Carlo simulation and option pricing models. Inherent in Monte-Carlo simulation and option pricing models are assumptions related to expected volatility and discount for lack of marketability of the underlying investment. Our investees estimate the volatility of these investments based on the historical performance of various broad market indices blended with various peer companies which they consider as having similar characteristics to the underlying investment, as well as consideration of price and volatility of relevant publicly traded securities such as SPAC warrants. Our investees also consider the probability of a successful merger when valuing SPAC equity.

 

27

 

 

Current Expected Credit Loss

 

Upon adoption of ASU 2016-13, the Company calculated an allowance for expected credit losses for its reinsurance balances receivable by applying a Probability of Default / Loss Given Default model. The model considers both the external collectability history as well as external loss history. The external loss history that the Company used included a long-term probability of liquidation study specific to insurance companies. Additionally, the life of each of the Company’s reinsurance treaties was also considered as the probability of default was calculated over the contractual length of the reinsurance contracts. The credit worthiness of a counterparty is evaluated by considering the credit ratings assigned by independent agencies and individually evaluating all the counterparties.

 

Upon adoption of ASU 2016-13, the Company calculated an approximately $0.1 million allowance for expected credit losses for its reinsurance balances receivable.

 

Valuation of Net Deferred Income Taxes

 

The provision for income taxes is calculated based on the expected tax treatment of transactions recorded in the Company’s consolidated financial statements. In determining its provision for income taxes, the Company interprets tax legislation in a variety of jurisdictions and makes assumptions about the expected timing of the reversal of deferred income tax assets and liabilities and the valuation of net deferred income taxes.

 

The ultimate realization of the deferred income tax asset balance is dependent upon the generation of future taxable income during the periods in which the Company’s temporary differences reverse and become deductible. A valuation allowance is established when it is more likely than not that all or a portion of the deferred income tax asset balance will not be realized. In determining whether a valuation allowance is needed, management considers all available positive and negative evidence affecting specific deferred income tax asset balances, including the Company’s past and anticipated future performance, the reversal of deferred income tax liabilities, and the availability of tax planning strategies. To the extent a valuation allowance is established in a period, an expense must be recorded within the income tax provision in the consolidated statements of income and comprehensive income.

 

Premium Revenue Recognition

 

The Company participates in reinsurance quota-share contracts and estimates the ultimate premiums for the contract period. These estimates are based on information received from the ceding companies, whereby premiums are recorded as written in the same periods in which the underlying insurance contracts are written and are based on cession statements from cedents. These statements are received quarterly and in arrears, and thus, for any reporting lag, premiums written are estimated based on the portion of the ultimate estimated premiums relating to the risks underwritten during the lag period. Premium estimates are reviewed by management periodically. Such review includes a comparison of actual reported premiums to expected ultimate premiums. Based on management’s review, the appropriateness of the premium estimates is evaluated, and any adjustments to these estimates are recorded in the period in which they are determined. Changes in premium estimates, including premiums receivable, are not unusual and may result in significant adjustments in any period. A significant portion of amounts included in the caption “Reinsurance balances receivable” in the Company’s consolidated balance sheets represent estimated premiums written, net of commissions, brokerage, and loss and loss adjustment expense, and are not currently due based on the terms of the underlying contracts. Premiums written are generally recognized as earned over the contract period in proportion to the risk covered. Additional premiums due on a contract that has no remaining coverage period are earned in full when written. Unearned premiums represent the unexpired portion of reinsurance provided. 

 

Deferred Policy Acquisition Costs

 

Policy acquisition costs are costs that vary with, and are directly related to, the successful production of new and renewal reinsurance business, and consist principally of commissions, taxes, and brokerage expenses. If the sum of a contract’s expected losses and loss expenses and deferred acquisition costs exceeds associated unearned premiums and expected investment income, a premium deficiency is determined to exist. In this event, deferred acquisition costs are written off to the extent necessary to eliminate the premium deficiency. If the premium deficiency exceeds deferred acquisition costs, then a liability is accrued for the excess deficiency. There were no premium deficiency adjustments recognized during the periods presented herein.

 

28

 

 

Loss and Loss Adjustment Expense Reserves

 

Loss and loss adjustment expense reserve estimates are based on estimates derived from reports received from ceding companies. These estimates are periodically reviewed by the Company’s management and adjusted as necessary. Since reserves are estimates, the final settlement of losses may vary from the reserves established and any adjustments to the estimates, which may be material, are recorded in the period they are determined.

 

Loss estimates may also be based upon actuarial and statistical projections, an assessment of currently available data, predictions of future developments, estimates of future trends and other factors. Significant assumptions used by the Company’s management and third-party actuarial specialists include loss development factor selections, initial expected loss ratio selections, and weighting of methods used. The final settlement of losses may vary, perhaps materially, from the reserves recorded. All adjustments to the estimates are recorded in the period in which they are determined. U.S. GAAP does not permit establishing loss reserves, which include case reserves and IBNR loss reserves, until the occurrence of an event which may give rise to a claim. As a result, only loss reserves applicable to losses incurred up to the reporting date are established, with no allowance for the establishment of loss reserves to account for expected future loss events. Generally, the Company obtains regular updates of premium and loss related information for the current and historical periods, which are utilized to update the initial expected loss ratio. We also experience lag between (i) claims being reported by the underlying insured to the Company’s cedent and (ii) claims being reported by the Company’s cedent to the Company. This lag may impact the Company’s loss reserve estimates. Cedent reports have pre-determined due dates (for example, thirty days after each month end). As a result, the lag depends in part upon the terms of the specific contract. The timing of the reporting requirements is designed so that the Company receives premium and loss information as soon as practicable once the cedent has closed its books. Accordingly, there should be a short lag in such reporting. Additionally, most of the contracts that have the potential for large single event losses have provisions that such loss notifications are provided to the Company immediately upon the occurrence of an event.

 

Stock-Based Compensation Expense

 

The Company uses the fair-value method of accounting for stock-based compensation awards granted. The Company has determined the fair value of its outstanding stock options on their grant date using the Black-Scholes option pricing model along with multiple Monte Carlo simulations to determine a derived service period as the options vest based upon meeting certain performance conditions. The Company determines the fair value of restricted stock units (“RSUs”) on their grant date using the fair value of the Company’s common stock on the date the RSUs were issued (for those RSU which vest solely based upon the passage of time). The fair value of these awards is recorded as compensation expense over the requisite service period, which is generally the expected period over which the awards will vest, with a corresponding increase to additional paid-in capital. When the stock options are exercised, or correspondingly, when the RSUs vest, the amount of proceeds together with the amount recorded in additional paid-in capital is recorded in shareholders’ equity.

 

Recent Accounting Pronouncements

 

See Item 8, Note 3 – Recently Adopted and Issued Accounting Standards in the Notes to the Consolidated Financial Statements for a discussion of recent accounting pronouncements and their effect on the Company.

 

Analysis of Financial Condition

 

As of March 31, 2023 Compared to December 31, 2022

 

Investments

 

See Note 4, Investments and Fair Value Disclosure, for information regarding the Company’s investments held at fair value as of March 31, 2023 and December 31, 2022.

 

Equity Method Investments

 

See Note 4, under the caption, “Equity Method Investments,” for information relating to the Company’s investments accounted for under the equity method.

 

29

 

 

Investments without Readily Determinable Fair Value

 

See Note 4, under the caption, “Investments without Readily Determinable Fair Value,” for information relating to Company investments for which readily determinable fair values do not exist.

 

Funds Deposited with Reinsured Companies

 

See Note 2, under the caption, “Funds Deposited with Reinsured Companies,” for information relating to FGRe’s collateral deposits.

 

Reinsurance Balances Receivable

 

Reinsurance balances receivable were $9.7 million, net of a current expected loss allowance of $0.1 million, as of March 31, 2023 compared to $9.3 million as of December 31, 2022, representing net amounts due to the Company under our quota-share agreements. As the Company estimates the ultimate premiums, loss expenses and other costs associated with some of these contracts, based on information received by us from the ceding companies, a significant portion of this balance is based on estimates and, ultimately, may not be collected by the Company.

 

Net Deferred Taxes

 

See Note 6, Income Taxes, for information relating to deferred income taxes.

 

Loss and Loss Adjustment Expense Reserves

 

See Note 5, Loss and Loss Adjustment Expense Reserves, for information relating to loss and loss adjustment expense and judgments required for recording such items.

 

Off Balance Sheet Arrangements

 

None.

 

Shareholders’ Equity

 

8.00% Cumulative Preferred Stock, Series A

 

The total number of Series A Preferred Stock shares outstanding as of March 31, 2023 and March 31, 2022 is 894,580.

 

Dividends on the Series A Preferred Stock are cumulative from the date of original issue and are payable quarterly on the 15th day of March, June, September and December of each year, when, as and if declared by our Board of Directors. Dividends are payable out of amounts legally available therefor at a rate equal to 8.00% per annum per $25.00 of stated liquidation preference per share, or $2.00 per share of Series A Preferred Stock per year. Our Board of Directors declared the first quarter 2023 dividend on the shares of Series A Preferred Stock on February 1, 2023. The Series A Preferred Stock shares trade on the Nasdaq Stock Market under the symbol “FGFPP.”

 

Common Stock

 

In June 2022, we sold a total of 2,750,000 shares of our common stock in an underwritten public offering, at a price of $1.58 per share, for net proceeds of approximately $3.8 million. On August 2, 2022, ThinkEquity, the underwriter with respect to the public offering, partially exercised its overallotment option and we sold an additional 71,770 shares of our common stock, at a price of 1.58 per share, for net proceeds of $0.1 million. The Company intends to use the net proceeds from the underwritten public offering for working capital and other general corporate purposes.

 

30

 

 

On November 3, 2022, the Company entered into a Sales Agreement with ThinkEquity LLC, pursuant to which the Company may offer and sell, from time to time through ThinkEquity LLC, shares of the Company’s common stock, having an aggregate offering price of up to $2,575,976, subject to the terms and conditions of the Sales Agreement. The Company filed a prospectus supplement to its registration statement on Form S-3. Under the Sales Agreement, the ThinkEquity LLC may sell the Shares in sales deemed to be an “at-the-market offering” as defined in Rule 415(a)(4) promulgated under the Securities Act of 1933. The Company is not obligated to make any sales of the shares under the Sales Agreement.

 

During the first quarter of 2023, the Company sold approximately 27,000 shares under the Sales Agreement for net proceeds of approximately $74,000.

 

The total number of common stock outstanding as of March 31, 2023 is 9,438,739.

 

Change in Shareholders’ Equity

 

The table below presents the primary components of changes to total shareholders’ equity for the three months ended March 31, 2023 and 2022.

 

   Preferred Shares Outstanding   Common Shares Outstanding   Treasury Shares  

Total Shareholders’

Equity attributable to FG Financial Group, Inc.

 
Balance, January 1, 2022   894,580    6,497,205    -   $34,009 
Stock compensation expense       30,796        63 
Dividends declared on Series A Preferred Stock               (447)
Net loss               (3,823)
Balance, March 31, 2022   894,580    6,528,001    -   $29,802 
                     
Balance, January 1, 2023   894,580    9,410,473       $37,295 
Common stock issuance        27,186         74 
Stock compensation expense       1,080        641 
Dividends declared on Series A Preferred Stock               (447)
Net Income               1,350 
Cumulative effect of adoption of accounting guidance for expected credit losses at January 1, 2023                  (106)
Balance, March 31, 2023   894,580    9,438,739       $38,807 

 

Results of Operations

 

Three Months Ended March 31, 2023 Compared with Three Months Ended March 31, 2022

 

Net Premiums Earned

 

Net premiums earned represent actual premiums earned on our reinsurance agreements as well as estimated premiums earned on our FAL agreement as disclosed previously. All actual and estimated premiums earned are the result of property and casualty assumed premium. For the three months ended March 31, 2023 and 2022, earned premiums are approximately $3.7 million and $2.5 million, respectively. The increase in reinsurance premiums was due primarily to the additional reinsurance agreement entered into with FAL to cover risks written by the syndicate during the calendar year 2023.

 

31

 

 

Net Investment Income

 

Net investment income (loss) for the three months ended March 31, 2023 and 2022 is as follows:

 

(in thousands)  Three months ended March 31, 
   2023   2022 
Investment income (loss):          
Realized loss on FedNat common stock  $-   $(2,877)
Change in unrealized holding loss on FedNat common stock   -    2,774 
Realized loss on Hagerty common stock   (16)     
Change in unrealized holding loss on Hagerty common stock   48      
Equity method earnings (losses)   2,680    (2,071)
Other   128    (172)
Net investment income (loss)  $2,840   $(2,346)

 

Other Income

 

Other income was approximately $30,000 and $25,000 for the three months ended March 31, 2023, and 2022, respectively, and is primarily comprised of service fee revenue we have earned under our SPAC Platform.

 

Net Losses and Loss Adjustment Expenses

 

Net losses and loss adjustment expenses (“LAE”) for the three months ended March 31, 2023 and 2022, were $1.9 million and $1.5 million, respectively. As discussed under Note 5, Loss and Loss Adjustment Expense Reserves, a portion of this charge represents an estimate based upon a full calendar year forecast of results provided to us by the ceding companies under our FAL arrangement.

 

General and Administrative Expenses

 

General and administrative expenses increased by $0.8 million to $2.5 million for the three months ended March 31, 2023, compared to $1.7 million for the three months ended March 31, 2022. The increase was primarily related to an increase in stock compensation expense.

 

Income Tax Expense (Benefit)

 

Our actual effective tax rate varies from the statutory federal income tax rates as shown in the following table.

 

($ in thousands)  Three months ended March 31, 
   2023   2022 
   Amount   %   Amount   % 
                 
Provision for taxes at U.S. statutory marginal income tax rate of 21%  $284    21.0%  $(803)   21.0%
Valuation allowance for deferred tax assets deemed unrealizable   (284)   (21.0)%   798    (20.9)%
Share-based compensation   -    -%   5    (0.1)%
Income tax benefit  $    %  $-    -%

 

32

 

 

As of March 31, 2023 and 2022, the Company has gross deferred tax assets of approximately $9.1 million and $6.6 million, respectively; however the Company has recorded a valuation allowance against all of its net deferred tax assets due to the uncertain nature surrounding our ability to realize these tax benefits in the future, resulting in a net deferred income tax asset of $0 as of March 31, 2023 and 2022.

 

Net Income (Loss)

 

Information regarding our net income (loss) and income (loss) per share for the three months ended March 31, 2023 and 2022 is as shown in the following table:

 

($ in thousands, except per share data)  Three months ended March 31, 
   2023   2022 
Basic and diluted:          
Net income (loss)   $1,350   $(3,823)
Dividends declared on Series A Preferred Shares   (447)   (447)
Income (loss) attributable to FG Financial Group, Inc. common shareholders    903    (4,270)
Weighted average common shares   9,421,993    6,447,568 
Income (loss) per common share   $0.10   $(0.66)
           
Weighted average common shares outstanding   9,421,993    6,447,568 
Income (loss) per share attributable to common shareholders  $0.10   $(0.66)

 

Liquidity and Capital Resources

 

The purpose of liquidity management is to ensure that there is sufficient cash to meet all financial commitments and obligations as they fall due. The liquidity requirements of the Company and its subsidiaries have been met primarily by funds generated from operations and from the proceeds from the sales of our common stock. Cash provided from these sources has historically been used for making investments, loss and LAE payments, as well as other operating expenses.

 

Cash Flows

 

The following table summarizes the Company’s consolidated cash flows for the three months ended March 31, 2023 and 2022.

 

($ in thousands)  Three months ended March 31, 
Summary of Cash Flows  2023   2022 
Cash and cash equivalents – beginning of period  $3,010   $15,542 
           
Net cash provided (used) by operating activities   750    (978)
Net cash provided (used) by investing activities   917    (5,616)
Net cash used by financing activities   (373)   (447)
Net increase (decrease) in cash and cash equivalents   1,294    (7,041)
           
Cash and cash equivalents – end of period  $4,304   $8,501 

 

33

 

 

For the quarter ended March 31, 2023, net cash provided by operating activities was approximately $0.8 million, the major drivers of which were as follows:

 

  Our net income of approximately $1.4 million for the period;
  An adjustment to our net income for $2.7 million related to unrealized gains associated with our equity method investments;
    A cash inflow of approximately $2.8 million for return of collateral due under our reinsurance agreements; and
 

A decrease in amounts due from cedants under reinsurance agreements of approximately $0.5 million

 

For the quarter ended March 31, 2023, net cash provided by investing activities was $0.9, the major drivers of which were as follows:

 

Approximately $0.9 million cash inflow from the sale of Hagerty common stock
Approximately $0.8 million cash inflow as a result of a distribution from the Fund
Approximately $0.7 million cash outflow as a result of investments in promissory notes

 

Net cash used by financing activities was approximately $0.4 million, as a result of a cash dividend declared on our Series A Preferred Shares, offset by issuance of common stock under the Sales Agreement.

 

For the quarter ended March 31, 2022, net cash used by operating activities was approximately $1.0 million, the major drivers of which were as follows:

 

  Our net loss of approximately $3.8 million for the period;
     
  An adjustment to our net loss for $2.0 million related to unrealized gains associated with our equity method investments; A cash inflow of approximately $3.2 million for distribution from equity method investments; and
     
  A cash outflow of approximately $1.8 million representing a receivable due to the Company from one of its equity investees. This receivable was settled, in cash, in April, 2022.

 

For the quarter ended March 31, 2022, net cash used by investing activities was $5.6 million primarily related to our increase investment in the Fund to sponsor FG Merger and FG Acquisition. Net cash used by financing activities was approximately $447,000, as a result of a cash dividend declared on our Series A Preferred Shares.

 

34

 

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Not applicable.

 

ITEM 4. CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures

 

The Company’s management performed an evaluation under the supervision and with the participation of the Company’s principal executive officer and principal financial officer of the effectiveness of the design and operation of the Company’s disclosure controls and procedures, as such term is defined in Rules 13a-15(e) promulgated under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as of March 31, 2023. Based upon this evaluation, the Company’s principal executive officer and principal financial officer concluded that the Company’s disclosure controls and procedures were effective as of the end of the period covered by this Quarterly Report on Form 10-Q to ensure that information required to be disclosed in the reports that the Company files or submits under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms; and (ii) accumulated and communicated to the Company’s management, including its principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

 

Changes in Internal Control Over Financial Reporting

 

There were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the quarter ended March 31, 2023 that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

35

 

 

PART II. OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

Information concerning pending legal proceedings is incorporated herein by reference to Note 10, “Commitments and Contingencies,” to the unaudited consolidated interim financial statements in Part I of this Form 10-Q.

 

ITEM 1A. RISK FACTORS

 

There have been no material changes to the risk factors previously disclosed in Part I, Item 1A. “Risk Factors” to our annual report on Form 10-K for the year ended December 31, 2022 filed with the SEC on March 24, 2023.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

None.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

None.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not applicable.

 

ITEM 5. OTHER INFORMATION

 

None.

 

ITEM 6. EXHIBITS

 

Exhibit   Description
31 .1*   Certification of Principal Executive Officer pursuant to Rule 13a-14(a) of the Exchange Act.
31.2*   Certification of Principal Financial Officer pursuant to Rule 13a-14(a) of the Exchange Act.
32.1**   Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2**   Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS*   Inline XBRL Instance Document.
101.SCH*   Inline XBRL Taxonomy Extension Schema.
101.CAL*   Inline XBRL Taxonomy Extension Calculation Linkbase.
101.DEF*   Inline XBRL Taxonomy Extension Definition Linkbase.
101.LAB*   Inline XBRL Taxonomy Extension Label Linkbase.
101.PRE*   Inline XBRL Taxonomy Extension Presentation Linkbase.
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

* Filed herewith.

** Furnished herewith.

 

36

 

 

FG FINANCIAL GROUP, INC.

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

    FG FINANCIAL GROUP, INC.
       
Date: May 12, 2023 By: /s/ Larry G. Swets, Jr.
      Larry G. Swets, Jr., Chief Executive Officer
      (principal executive officer)
       
Date: May 12, 2023 By: /s/ Hassan R. Baqar
      Hassan R. Baqar, Chief Financial Officer
      (principal financial officer)

 

37